Targeting HDAC3 to overcome the resistance to ATRA or arsenic in acute promyelocytic leukemia through ubiquitination and degradation of PML-RARα 【IF: 12】Cell Death Differ. 2023 Mar 9 RGFP966 purchased from AbMole
